Skip to Main Content
Contribute Try STAT+ Today

Good morning, everyone, and nice to see you again. We have returned from an extended weekend respite that was due to a holiday on this side of the pond. But now, of course, we are gearing up for the usual routine of meetings, deadlines, and the like. No doubt, you can relate. So please join us for a refreshing cup of stimulation as we dig in for a busy day. Remember, no prescription is required, which also means you do not have to puzzle over rebates or copays. Meanwhile, here are some tidbits. Hope your day is successful and, as always, do keep in touch …

A former Biogen (BIIB) employee filed a lawsuit accusing the drug maker of failing to accommodate his Parkinson’s disease, even as the company was developing a drug for the condition, the Boston Business Journal writes. Aldrin Carao, who was hired in 2012 and had been diagnosed with the disease seven years earlier, claims that Biogen discriminated against him and backtracked on accommodations it had made for his disease before abruptly firing him in February 2016. His disease worsened over his final two years of employment, impacting his speech and ability to type.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.